Covid-19 Update to QAA No. 11 - Extension of monitoring intervals for medicines in primary care

30th Apr 2020

The RDTC has updated COVID-19 QAA No. 11 - Extension of monitoring intervals for medicines in primary care. In light of the Second phase of NHS response to COVID-19: Letter from Sir Simon Stevens and Amanda Pritchard” letter, this QAA had been revised; recommendations for DMARDs, lithium and antipsychotics are now more closely aligned with standard practice (as per GMMMG SCPs), with some flexibility maintained to allow for decisions to be made on a case-by-case basis.